Release of active tissue factor by human arterial smooth muscle cells

Circulation Research

Volumn 87, Issue 2, 2000, Pages 126-132

  Schecter, Alison D ^a   Spirn, Benjamin ^a   Rossikhina, Maria ^a   Giesen, Peter L A ^a   Bogdanov, Vladimir ^a   Fallon, John T ^a   Fisher, Edward A ^a   Schnapp, Lynn M ^a   Nemerson, Yale ^a   Taubman, Mark B ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Microparticles; Smooth muscle; Thrombosis; Tissue factor

Indexed keywords

THROMBOPLASTIN;

ARTICLE; ATHEROSCLEROSIS; CYTOMETRY; DISEASE ASSOCIATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; THROMBOSIS; TISSUE DISTRIBUTION; WESTERN BLOTTING;

EID: 0034698095     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.87.2.126     Document Type: Article

References (42)

1. Tissue factor: Then and now
2. The structural biology of expression and function of tissue factor
3. Tissue factor in the pathogenesis of atherosclerosis
4. Regulation of tissue factor gene expression in human monocytic and endothelial cells
5. Tissue factor is rapidly induced in arterial smooth muscle after balloon injury
6. Tissue factor mediates prolonged procoagulant activity on the luminal surface of balloon-injured aortas in rabbits
7. Hirudin reduces tissue factor expression in neointima after balloon injury in rabbit femoral and porcine coronary arteries
8. Sequential injury of the rabbit abdominal aorta induces intramural coagulation and luminal narrowing independent of intimal mass: Extrinsic pathway inhibition eliminates luminal narrowing
9. Differential expression of tissue factor protein in directional atherectomy specimens from patients with stable and unstable coronary syndromes
10. Localization and activity of tissue factor in human aortic atherosclerotic lesions
11. Macrophages, smooth muscle cells, and tissue factor in unstable angina: Implications for cell-mediated thrombogenicity in acute coronary syndromes
12. Identification of active tissue factor in human coronary atheroma
13. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque
14. In situ localization of tissue factor in human atherosclerotic plaques by binding of digoxigenin-labeled factors VIIa and X
15. Tissue factor and hemostasis
16. Intimal tissue factor activity is released from the arterial wall after injury
17. Measuring tissue factor (factor III) activity in plasma
18. Whole blood tissue factor procoagulant activity is elevated in patients with sickle cell disease
19. Blood-borne tissue factor: A new view of thrombosis
20. Increased plasma tissue factor levels in acute myocardial infarction
21. Tissue factor expression in human arterial smooth muscle cells: TF is present in three cellular pools after growth factor stimulation
22. Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation
23. Lipid association, but not the transmembrane domain, is required for tissue factor activity: Substitution of the transmembrane domain with a phosphatidylinositol anchor
24. Platelet-derived growth factor-specific regulation of the JE promoter in rat aortic smooth muscle cells
25. The synthesis of sulfated dextran beads for isolation of human plasma coagulation factors II, IX, and X
26. SM-20 is a novel 40-kd protein whose expression in the arterial wall is restricted to smooth muscle
27. Interleukin 1: A mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids
28. Regulation of coagulation by a multivalent Kunitz-type inhibitor
29. Presence of tissue factor pathway inhibitor in human atherosclerotic plaques is associated with reduced tissue factor activity
30. Factor VII binding to tissue factor in reconstituted phospholipid vesicles: Induction of cooperativity by phosphatidylserine
31. Apoprotein B100 has a prolonged interaction with the translocon during which its lipidation and translocation change from dependence on the microsomal triglyceride transfer protein to independence
32. Lipoproteins containing apolipoprotein B-100 are secreted by the heart
33. The low density lipoprotein receptor-related protein mediates the cellular degradation of tissue factor pathway inhibitor
34. Tissue-factor pathway inhibitor and lipoproteins: Evidence for association with and regulation by LDL in human plasma
35. Apoptosis is associated with increased cell surface tissue factor procoagulant activity
36. Apoptotic vascular endothelial cells become procoagulant
37. Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: A role for apoptosis in plaque thrombogenicity
38. Annexin V, the regulator of phosphatidylserine-catalyzed inflammation and coagulation during apoptosis
39. Association of tissue factor activity with the surface of cultured cells
40. Fibroblast tissue factor: Calcium and ionophore induce shape changes, release of membrane vesicles, and redistribution of tissue factor antigen in addition to increased procoagulant activity
41. Monocyte vesiculation is a possible mechanism for dissemination of membrane-associated procoagulant activities and adhesion molecules after stimulation by lipopolysaccharide
42. 1 functions as a receptor for tenascin, fibronectin, and vitronectin